Evolving Larger: Dosing Anti-Tuberculosis (TB) Drugs in an Obese World

E-ISSN： 1873-4286|21|32|4748-4751

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.32, 2015-10, pp. : 4748-4751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1177-1185

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs in Clinical Development: An Overview

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs with Novel Mechanisms of Action

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-01 ,pp. : 1956-1967

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 105-105

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 53-53

Bentham Science Publishers

Access to resources Recommend Favorite